ImageneBio is a clinical-stage biotechnology company dedicated to developing therapeutics for patients with immunological, autoimmune, and inflammatory diseases with differentiated clinical profiles. The company’s program, IMG-007, is a receptor targeting, nondepleting anti-OX40 monoclonal antibody with multiple differentiating features. Imagene has completed Phase 1b/2a clinical trials of IMG-007 in both atopic dermatitis and alopecia areata and is currently conducting a Phase 2b clinical trial of IMG-007 in patients with moderate-to-severe atopic dermatitis.
| Website | http://www.imagenebio.com/ |
| Employees | 50 (40 on RocketReach) |
| Founded | 2019 |
| Address | 12526 High Bluff Drive Suite 345, San Diego, California 92130, US |
| Industry | Biotechnology Research |
Looking for a particular ImageneBio employee's phone or email?
ImageneBio Questions
Kristin Yarema is the CEO of ImageneBio.
40 people are employed at ImageneBio.
ImageneBio is based in San Diego, California.
Top ImageneBio Employees
-
Kristin Yarema
Chief Executive Officer at ImageneBio
Los Angeles, CA, US25+ -
Renuka Sivendran
Chief Technical Officer at ImageneBio
United States35+ -
Shailender Gunnala
SVP Head of IT, AI and Facilities at ImageneBio
Thousand Oaks, CA, US25+ -
25
-
Francis F
Senior VP of Operations, Non-clinical Developmemt and GM of HZ R and D Center at ImageneBio
Hangzhou, Zhejiang, China1 -
Matt Robbins
General Counsel at ImageneBio
San Diego, CA, US21 -
Joseph Slattery
Director, Audit Committee Chair at ImageneBio
Raleigh, NC, US25+ -
Nicki Tieken
Director, Clinical Operations at ImageneBio
Grapevine, TX, US22
